Pantoprazol Biomo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Biomo, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoprazol Biomo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Biomo is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates healing of erosions caused by chronic acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazol Biomo is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased gas formation. - Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Vitamin B12 deficiency: fatigue, neuropathy with long‑term use. - Bone fracture risk: increased incidence with prolonged therapy. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazol Biomo, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term use: evaluate need for continued therapy after 8‑12 weeks. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for falls. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Biomo may interact with several medicines. Clinical relevance varies, so monitoring is advised.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption leading to therapeutic failure. - Atazanavir: decreased antiviral exposure, risking HIV treatment failure.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent coagulation monitoring. - Digoxin: elevated serum levels may occur, necessitating dose adjustment. - Methotrexate: reduced renal clearance can increase toxicity, especially at high doses. - Clopidogrel: diminished antiplatelet effect, consider alternative therapy. - Iron supplements: decreased iron absorption, advise spacing doses by at least 2 hours.